Twist Bioscience

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Fridge-free tetanus-diphtheria vaccine passes first human trial Stablepharma's SPVX02 vaccine remains stable at 30°C for two years, new Phase I data shows, easing cold-chain dependence
  2. FDA escalates action against Dabur India over systemic data-integrity and cGMP failures The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process...
  3. Thermo Fisher Scientific launches new general purpose centrifuges with natural refrigerant cooling New X2 and S2 Series centrifuges combine precise performance with improved sustainability for research, biopharma and clinical laboratories
  4. FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence FUJIFILM Biotechnologies today announced a planned leadership evolution as the Company enters its next phase of execution and sustainable growth
  5. Tasrif Pharmaceutical granted second US patent for CD155-targeting antibody developed with Abzena's humanisation and immunogenicity platforms Expanded intellectual property supports development of humanised anti-CD155 antibody and next-generation cancer immunotherapy modalities

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

Related Content

Research & Development
Amazon rolls out AI-powered platform Amazon Bio Discovery for drug discovery

Amazon rolls out AI-powered platform Amazon Bio Discovery for drug discovery

The new application will assist with drug design, allowing more researchers to access leading AI models rather than just those with AI and coding skills. Already in use with partners such as MSK, the platform has reduced the timeline for antibody design for potential pediatric cancer therapies from months to weeks
Pharmaceutical
Twist Bioscience puts antibody optimisation potential to use

Twist Bioscience puts antibody optimisation potential to use

Partnership to apply antibody optimisation platform to the targeting arm of a bispecific antibody
Manufacturing
Twist Bioscience and LakePharma share resources for antibody platform

Twist Bioscience and LakePharma share resources for antibody platform

Twist will provide its antibody discovery platform, LakePharma will provide development services
Manufacturing
Automated microfluidics for gene editing is in the works

Automated microfluidics for gene editing is in the works

Oxford Genetics has announced a partnership to optimise the way laboratories deliver gene editing to cells and interrogate the resultant products
Research & Development
Leaders of transformation

Leaders of transformation

Haig Armaghanian, founder and CEO of Haig Barrett, explores how synthetic biology pioneers are revolutionising therapeutic development
Subscribe now